MARATTO

article · International journal of HIV and AIDS research.

Correlation between sequencing results on plasma and on dried blood Spot for the determination of non-B subtypes of HIV Type 1 in Nrsquo;djamena, chad: About 30 samples

Abstract

Context: Easily applicable, the Dried Blood Spot (DBS) makes it possible to collect blood drawn from a tube or by pricking in the heel or finger, both in town and in decentralized regions. They allow samples to be stored at room temperature or cold, in airtight bags to prevent humidity. Objective: The aim of this work was to determine the correlation between the results of sequencing on liquid plasma and on DBS in N’Djamena, Chad. Methods: The blood of 50 patients living with HIV was drawn on a tube with EDTA and 30 of them were randomly put on Whatman ® 903 type DBS. The drying was done overnight at room temperature. Storage was done at -20 ° C. Viral RNA extraction was performed with the QiAamp Viral RNA mini kit. The viral load on DBS and on plasma was carried out at LRS CHU-ULg. The determination of the variants was obtained after analysis on the Stanford University/HIV Drug Resistance Database site. The interpretation of the resistances is made in accordance with the algorithm of the ANRS AC11. Results: An amplification rate of 80% is obtained on the DBS with a detection limit of the blotter is 3.33 log10 copies of RNA/ml. The subtypes obtained on the Protease sequences, which is the least changing region of the virus were retained. CRF02_AG is the most represented both on DBS with 29.17% and on plasma with 30.23%. Sequencing on DBS showed the presence of the K subtype (12.5%) at the level of the Reverse Transcriptase while it is absent in the plasma after sequencing. Conclusion: An amplification success rate of 80% compared to plasma was observed in this study. However, DBS can be useful for the evaluation of antiretroviral therapy for non-B subtypes.

Research topics

  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.33545/2664990x.2019.v1.i1a.5

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.